Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 7

    1.

    Influence of atazanavir 200 mg on the intracellular and plasma pharmacokinetics of saquinavir and ritonavir 1600/100 mg administered once daily in HIV-infected patients.

    Ford J, Boffito M, Maitland D, Hill A, Back D, Khoo S, Nelson M, Moyle G, Gazzard B, Pozniak A.

    J Antimicrob Chemother. 2006 Nov;58(5):1009-16. Epub 2006 Sep 19.PMID: 16984898 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Pharmacokinetics of saquinavir hard-gel/ritonavir and atazanavir when combined once daily in HIV Type 1-infected individuals administered different atazanavir doses.

    Boffito M, Maitland D, Dickinson L, Back D, Hill A, Fletcher C, Moyle G, Nelson M, Gazzard B, Pozniak A.

    AIDS Res Hum Retroviruses. 2006 Aug;22(8):749-56.PMID: 16910830 [PubMed - indexed for MEDLINE]Related articles

    3.

    Practical perspectives on the use of tipranavir in combination with other medications: lessons learned from pharmacokinetic studies.

    Boffito M, Maitland D, Pozniak A.

    J Clin Pharmacol. 2006 Feb;46(2):130-9. Review.PMID: 16432264 [PubMed - indexed for MEDLINE]Related articles

    4.

    Tenofovir and didanosine: a dangerous liaison.

    Waters L, Maitland D, Moyle GJ.

    AIDS Read. 2005 Aug;15(8):403-6, 413. Review. No abstract available. PMID: 16110555 [PubMed - indexed for MEDLINE]Related articles

    5.

    Early virologic failure in HIV-1 infected subjects on didanosine/tenofovir/efavirenz: 12-week results from a randomized trial.

    Maitland D, Moyle G, Hand J, Mandalia S, Boffito M, Nelson M, Gazzard B.

    AIDS. 2005 Jul 22;19(11):1183-8.PMID: 15990571 [PubMed - indexed for MEDLINE]Related articles

    6.

    Boosted saquinavir hard gel formulation exposure in HIV-infected subjects: ritonavir 100 mg once daily versus twice daily.

    Boffito M, Maitland D, Dickinson L, Back D, Hill A, Fletcher C, Moyle G, Nelson M, Gazzard B, Pozniak A.

    J Antimicrob Chemother. 2005 Apr;55(4):542-5. Epub 2005 Feb 18.PMID: 15722388 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    The pharmacokinetics of HIV protease inhibitor combinations.

    Boffito M, Maitland D, Samarasinghe Y, Pozniak A.

    Curr Opin Infect Dis. 2005 Feb;18(1):1-7. Review.PMID: 15647693 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...